Catherine C Smith (Catherine Smith)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Blood advances

Blood

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

UCSF Helen Diller Family Comprehensive Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSF Helen Diller Family Comprehensive Cancer Center

United States

Assistant Professor :: Medicine

Publications

Fieke W Hoff, William Blum, Ying Huang, Rina Li Welkie, Ronan Swords, Jennifer Dunlap, Eytan M Stein, Tara L Lin, Kellie J Archer, Prapti A Patel, Robert H Collins, Maria R Baer, Vu H Duong, Martha L Arellano, Wendy Stock, Olatoyosi Odenike, Robert L Redner, Tibor J Kovacsovics, Michael W Deininger, Joshua F Zeidner, Rebecca L Olin, Catherine C Smith, James M Foran, Gary J Schiller, Emily Curran, Kristin L Koenig, Nyla A Heerema, Timothy L Chen, Molly Martycz, Mona Stefanos, Leonard Rosenberg, Brian J Druker, Ross L Levine, Amy Burd, Ashley O Yocum, Uma Borate, Alice S Mims, John C Byrd, Yazan F Madanat
Beat-AML 2024 ELN-Refined Risk Stratification for Older Adults with Newly Diagnosed AML Given Lower-Intensity Therapy. Blood advances (2024)
Cheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, Cyrille L Delley, Andrew Koh, Elaine Tran, Iain C Clark, Corey E Hayford, Chris D'Amato, Yi Xue, Kristina M Fontanez, Aaron A May-Zhang, Trinity Smithers, Yigal Agam, Qian Wang, Hai-Ping Dai, Ritu Roy, Aaron C Logan, Alexander E Perl, Adam R Abate, Adam Olshen, Catherine C Smith
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia. Nature communications 15 (1) (2024)
Vanessa E Kennedy, Catherine C Smith
FLT3 targeting in the modern era: from clonal selection to combination therapies. International journal of hematology (2023)
Zhongxia Qi, Catherine C Smith, Neil P Shah, Jingwei Yu
Complex Genomic Rearrangements Involving ETV6 :: ABL1 Gene Fusion in an Individual with Myeloid Neoplasm. Genes 14 (10) (2023)
Catherine C Smith, Mark J Levis, Alexander E Perl, Jason E Hill, Matt Rosales, Erkut Bahceci
Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib. Blood advances 6 (7) (2022)
Alexander E Perl, Naoko Hosono, Pau Montesinos, Nikolai A Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C Smith, Mark J Levis, Stephen A Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V Tiu, Jessica K Altman
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib. Blood cancer journal 12 (5) (2022)
Naval G Daver, Alexander E Perl, Joseph Maly, Mark Levis, Ellen Ritchie, Mark R Litzow, James McCloskey, Catherine C Smith, Gary Schiller, Terrence Bradley, Ramon V Tiu, Kiran Naqvi, Monique Dail, Deanna Brackman, Satya Siddani, Jing Wang, Brenda J Chyla, Paul Lee, Jessica K Altman
Venetoclax Plus Gilteritinib for FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Catherine C Smith
Roman warfare: targeting of support cells in AML. Blood 133 (6) (2019)
Catherine C Smith, Amy Paguirigan, Grace R Jeschke, Kimberly C Lin, Evan Massi, Theodore C Tarver, Chen-Shan Chin, Saurabh Asthana, Adam Olshen, Kevin J Travers, Susana Wang, Mark J Levis, Alexander E Perl, Jerald P Radich, Neil P Shah
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis. Blood 130 (1) (2017)

Catherine C Smith.css-eqlu8i{font-size:small;padding-left:4px;} (Catherine Smith)

Publication Activity (10 Years)

Top Topics

Top Venues

Catherine C Smith (Catherine Smith)